The future outlook on allergen immunotherapy in children: 2018 and beyond
Abstract Allergen immunotherapy (AIT) is the only currently available immune-modifying and aetiological treatment for patients suffering from IgE-mediated diseases. In childhood, it represents a suitable therapeutic option to intervene during the early phases of respiratory allergic diseases such as...
Main Authors: | Stefania Arasi, Giovanni Corsello, Alberto Villani, Giovanni Battista Pajno |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | Italian Journal of Pediatrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13052-018-0519-4 |
Similar Items
-
Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews
by: Ulugbek Nurmatov, et al.
Published: (2017-08-01) -
Sublingual and subcutaneous allergen-specific immunotherapy as
a method of treatment of patients with inhalant allergy – a review
of the literature
by: Angelika Pawlak, et al.
Published: (2021-09-01) -
Long-term effects of allergen sublingual immunotherapy
by: Andrzej Bozek, et al.
Published: (2019-05-01) -
Pollen Serum Specific IgE Sensitization in Respiratory Allergic Patients in Jakarta, Indonesia
by: Iris Rengganis, et al.
Published: (2017-11-01) -
The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy
by: Nishelle D’souza, et al.
Published: (2021-08-01)